153 related articles for article (PubMed ID: 21212844)
1. Livedoid thrombotic vasculopathy responding to doxycycline therapy.
Keller MS; Lee J; Webster GF
J Clin Aesthet Dermatol; 2008 Nov; 1(4):22-4. PubMed ID: 21212844
[TBL] [Abstract][Full Text] [Related]
2. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial.
Weishaupt C; Strölin A; Kahle B; Kreuter A; Schneider SW; Gerss J; Eveslage M; Drabik A; Goerge T
Lancet Haematol; 2016 Feb; 3(2):e72-9. PubMed ID: 26853646
[TBL] [Abstract][Full Text] [Related]
4. Baricitinib is potentially effective in the treatment of refractory livedoid vasculopathy.
Han Y; Tu P
Front Immunol; 2022; 13():1008392. PubMed ID: 36389811
[TBL] [Abstract][Full Text] [Related]
5. Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen.
Yang CH; Ho HC; Chan YS; Liou LB; Hong HS; Yang LC
Br J Dermatol; 2003 Sep; 149(3):647-52. PubMed ID: 14511004
[TBL] [Abstract][Full Text] [Related]
6. Penile Livedoid Vasculopathy: First Reported Case.
Hallak A; Bennett W; Tanbir MA; Donthamsetty SR; Vincent B
Case Rep Vasc Med; 2023; 2023():6920383. PubMed ID: 37440957
[TBL] [Abstract][Full Text] [Related]
7. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC
Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971
[TBL] [Abstract][Full Text] [Related]
8. Treatment for Livedoid Vasculopathy: A Systematic Review.
Micieli R; Alavi A
JAMA Dermatol; 2018 Feb; 154(2):193-202. PubMed ID: 29141075
[TBL] [Abstract][Full Text] [Related]
9. Dermoscopic features of livedoid vasculopathy.
Hu SC; Chen GS; Lin CL; Cheng YC; Lin YS
Medicine (Baltimore); 2017 Mar; 96(11):e6284. PubMed ID: 28296736
[TBL] [Abstract][Full Text] [Related]
10. Livedoid vasculopathy: A review with focus on terminology and pathogenesis.
Eswaran H; Googe P; Vedak P; Marston WA; Moll S
Vasc Med; 2022 Dec; 27(6):593-603. PubMed ID: 36285834
[TBL] [Abstract][Full Text] [Related]
11. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
[TBL] [Abstract][Full Text] [Related]
12. Livedoid vasculopathy and its association with factor V Leiden mutation.
Yong AA; Tan AW; Giam YC; Tang MB
Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
[TBL] [Abstract][Full Text] [Related]
13. Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin.
Abou Rahal J; Ishak RS; Otrock ZK; Kibbi AG; Taher AT
J Thromb Thrombolysis; 2012 Nov; 34(4):541-4. PubMed ID: 22592843
[TBL] [Abstract][Full Text] [Related]
14. A Case of Livedoid Vasculopathy Successfully Treated with Sulodexide.
Song CH; Shin DS; Jang JW; Kim TL; Kim YG; Kim JS; Seo HM
Ann Dermatol; 2020 Dec; 32(6):508-511. PubMed ID: 33911794
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy.
Seguí M; Llamas-Velasco M
Front Med (Lausanne); 2022; 9():993515. PubMed ID: 36569162
[TBL] [Abstract][Full Text] [Related]
16. Livedoid vasculopathy - A diagnostic and therapeutic challenge.
Burg MR; Mitschang C; Goerge T; Schneider SW
Front Med (Lausanne); 2022; 9():1012178. PubMed ID: 36262273
[TBL] [Abstract][Full Text] [Related]
17. A Phase II Multicenter Trial With Rivaroxaban in the Treatment of Livedoid Vasculopathy Assessing Pain on a Visual Analog Scale.
Drabik A; Hillgruber C; Goerge T
JMIR Res Protoc; 2014 Dec; 3(4):e73. PubMed ID: 25500152
[TBL] [Abstract][Full Text] [Related]
18. Livedoid vasculopathy associated with heterozygous protein C deficiency.
Boyvat A; Kundakçi N; Babikir MO; Gürgey E
Br J Dermatol; 2000 Oct; 143(4):840-2. PubMed ID: 11069468
[TBL] [Abstract][Full Text] [Related]
19. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of an anti-TNF-alpha agent in refractory livedoid vasculopathy: a retrospective analysis.
Gao Y; Jin H
J Dermatolog Treat; 2022 Feb; 33(1):178-183. PubMed ID: 32116074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
